Cargando…
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
Public health vaccination recommendations for COVID-19 primary series and boosters in previously infected individuals differ worldwide. As infection with SARS-CoV-2 is often asymptomatic, it remains to be determined if vaccine immunogenicity is comparable in all previously infected subjects. This st...
Autores principales: | Nantel, Sabryna, Bourdin, Benoîte, Adams, Kelsey, Carbonneau, Julie, Rabezanahary, Henintsoa, Hamelin, Marie-Ève, McCormack, Deirdre, Savard, Patrice, Longtin, Yves, Cheng, Matthew P., De Serres, Gaston, Corbeil, Jacques, Gilca, Vladimir, Baz, Mariana, Boivin, Guy, Quach, Caroline, Decaluwe, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614167/ https://www.ncbi.nlm.nih.gov/pubmed/36311736 http://dx.doi.org/10.3389/fimmu.2022.930252 |
Ejemplares similares
-
The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
por: Racine, Étienne, et al.
Publicado: (2022) -
Human Bocavirus Infections in Hospitalized Children and Adults
por: Longtin, Jean, et al.
Publicado: (2008) -
Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019) -
Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
por: Papenburg, Jesse, et al.
Publicado: (2012) -
RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines
por: Chang, W. L. William, et al.
Publicado: (2020)